ProfileGDS5678 / 1447518_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 22% 23% 23% 21% 24% 42% 21% 23% 24% 23% 22% 29% 22% 31% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5441922
GSM967853U87-EV human glioblastoma xenograft - Control 22.5281223
GSM967854U87-EV human glioblastoma xenograft - Control 32.5386523
GSM967855U87-EV human glioblastoma xenograft - Control 42.4564521
GSM967856U87-EV human glioblastoma xenograft - Control 52.5039524
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.0644242
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5280421
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.520423
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.5361424
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.522123
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.5132322
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.632429
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5081822
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.703531